German Christopher Paul

Track

Insider profile

Performance

Overall performance
1.4
Performance over holding periods
1.4
30 days 90 days 120 days
Average return 3% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
1 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
German Christopher Paul's trades of Rhythm Pharmaceuticals, Inc.'s stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Sale
Price
386.16
Quantity 57,486 -15.5%
Value US$2,281,504
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-05-19 2026-05-15
S Sale
57,486 -15.5%
386.16
US$2,281,504 		57,486 -15.5% 386.16 US$2,281,504
2026-03-06 2026-03-04
PlS Planned sale
29,485 -19.2%
392.91
US$3,992,706 		29,485 -19.2% 392.91 US$3,992,706
2025-08-14 2025-08-12
PlS Planned sale
6,817 +17.5%
364.22
US$953,534 		6,817 +17.5% 364.22 US$953,534
2025-08-12 2025-08-12
PrS Proposed sale
1,500
94.31
US$141,465 		1,500 94.31 US$141,465
2025-07-11 2025-07-09
PlS Planned sale
1,850 -66.7%
85.00
US$157,250 		1,850 -66.7% 85.00 US$157,250
2025-07-11 2025-07-09
PlS Planned sale
1,967 -41.5%
76.75
US$150,967 		1,967 -41.5% 76.75 US$150,967
2025-07-09 2025-07-09
PrS Proposed sale
3,817
65.14
US$248,639 		3,817 65.14 US$248,639
2025-06-12 2025-06-10
PlS Planned sale
2,069 -52.3%
67.19
US$139,016 		2,069 -52.3% 67.19 US$139,016
2025-06-10 2025-06-10
PrS Proposed sale
2,069
66.72
US$138,044 		2,069 66.72 US$138,044
2025-03-24 2025-03-21
PlS Planned sale
344 -10.6%
54.23
US$18,655 		344 -10.6% 54.23 US$18,655
2025-02-19 2025-02-19
PlS Planned sale
635 -23.5%
57.22
US$36,335 		635 -23.5% 57.22 US$36,335
2024-04-03 2024-04-02
PlS Planned sale
368 -31.6%
41.76
US$15,368 		368 -31.6% 41.76 US$15,368